|
Private placement
|
4
|
Resverlogix Corp.
|
Aug 30, 2018 08:03AM
|
|
Re: PNH
|
4
|
Resverlogix Corp.
|
Sep 24, 2015 09:19PM
|
|
Re: Win or lose....one thing we know for sure
|
4
|
Resverlogix Corp.
|
Sep 02, 2019 11:43AM
|
|
Re: Roth research report
|
4
|
Resverlogix Corp.
|
Nov 01, 2018 04:36PM
|
|
Re: A vs V
|
4
|
Resverlogix Corp.
|
Mar 29, 2019 09:04PM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
4
|
Resverlogix Corp.
|
Jun 30, 2015 04:41PM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
4
|
Resverlogix Corp.
|
May 10, 2019 05:09PM
|
|
Re: EAS Poster Sessions Apabetalone is there
|
4
|
Resverlogix Corp.
|
Apr 15, 2017 10:41AM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 06:45PM
|
|
Re: Sub-study Forest Plot
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 03:00PM
|
|
Re: Naz listing?
|
4
|
Resverlogix Corp.
|
Apr 19, 2019 05:06PM
|
|
Re: If we follow AMRN's pattern...
|
4
|
Resverlogix Corp.
|
Aug 08, 2019 08:27PM
|
|
Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
5
|
Resverlogix Corp.
|
Nov 12, 2019 07:35AM
|
|
Re: I'm Weary of Articles that Reference....
|
5
|
Resverlogix Corp.
|
Mar 13, 2019 01:45PM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
5
|
Resverlogix Corp.
|
Mar 31, 2019 08:39AM
|
|
Seeking Alpha mention
|
5
|
Resverlogix Corp.
|
Aug 23, 2019 07:43AM
|
|
Endocyte vs Zenith
|
5
|
Zenith Epigenetics
|
Sep 13, 2018 06:14PM
|
|
Re: Orphan Disease Program
|
5
|
Resverlogix Corp.
|
Sep 25, 2015 02:33PM
|
|
Re: Amgen's Acclaimed 20% MACE reduction referred to as "slashing heart attack rates"
|
5
|
Resverlogix Corp.
|
Mar 17, 2017 03:00PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
5
|
Resverlogix Corp.
|
Jan 14, 2019 07:09PM
|
